Novartis Loses Bid For Inhaler Patent On Appeal
Appellate officials have revoked a Novartis patent for an inhaler, finding that skilled scientists at the time would think it was obvious to combine the claimed compounds in the aerosol composition...To view the full article, register now.
Already a subscriber? Click here to view full article